Cargando…
A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression
Metastasis and resistance are main causes to affect the outcome of the current anticancer therapies. Heat shock protein 90 (Hsp90) as an ATP-dependent molecular chaperone takes important role in the tumor metastasis and resistance. Targeting Hsp90 and downregulating its expression show promising in...
Autores principales: | Zhou, Yi, Miao, Yingling, Huang, Qiudi, Shi, Wenwen, Xie, Jiacui, Lin, Jiachang, Huang, Pei, Yue, Chengfeng, Qin, Yuan, Yu, Xiyong, Wang, He, Qin, Linghao, Chen, Jianhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372829/ https://www.ncbi.nlm.nih.gov/pubmed/37521875 http://dx.doi.org/10.1016/j.apsb.2022.11.024 |
Ejemplares similares
-
pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer
por: Wang, He, et al.
Publicado: (2021) -
Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
por: Wang, He, et al.
Publicado: (2020) -
CKS1B as Drug Resistance-Inducing Gene—A Potential Target to Improve Cancer Therapy
por: Shi, Wenwen, et al.
Publicado: (2020) -
Delivering bioactive cyclic peptides that target Hsp90 as prodrugs
por: Huo, Yuantao, et al.
Publicado: (2019) -
Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy
por: Du, Min, et al.
Publicado: (2022)